Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EPX-100 Drug-Drug Interaction Study in Healthy Participants
NCT07824193Phase 1Completed
- Sponsor
- Epygenix Therapeutics
- Start
- Jan 2025
- Primary completion
- Apr 2025
- Countries
- 1
01
Overview
Phase 1, open-label trial of clemizole (3 arms), sponsored by Epygenix Therapeutics. Primary endpoints: Area Under The Concentration-time Curve from Time 0 to the Last Observed Non-zero Concentration, Area Under The Concentration-time Curve from Time 0 extrapolated to infinity and 1 more. Started Jan 2025; status: completed.
02
Drugs
clemizole
Beyond the preview
Go deeper on NCT07824193.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07824193.